Skip to main content

Animations

MJFF Publications

4231 - 4240 of 8606 Results
Title
Year
  • Year
  • 2024
  • 2019
  • 2021
  • 2018
  • 2015
  • 2020
  • 2020
  • 2023
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49258-1
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25629
    Citation Count: 93
  • Summary Details
    OPEN
    Title: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8
    Citation Count: 185
  • Summary Details
    OPEN
    Title: High complement levels in astrocyte‐derived exosomes of Alzheimer disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25172
    Citation Count: 314
  • Summary Details
    OPEN
    Title: Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2015.11.007
    Citation Count: 122
  • Summary Details
    OPEN
    Title: Validation of human microRNA target pathways enables evaluation of target prediction tools
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkaa1161
    Citation Count: 56
  • Summary Details
    RESTRICTED
    Title: Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2020.113357
    Best OA location URL:
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00555-4
    Citation Count: 16
  • Summary Details
    OPEN
    Title: On‐Demand Cueing for Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29762
    Best OA location URL:
    Citation Count: 13
  • Summary Details
    OPEN
    Title: POLCAM: instant molecular orientation microscopy for the life sciences
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-024-02382-8
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.